Royce & Associates LP Purchases 4,787 Shares of Molina Healthcare, Inc. (NYSE:MOH)

Royce & Associates LP grew its position in Molina Healthcare, Inc. (NYSE:MOH) by 15.5% in the fourth quarter, Holdings Channel.com reports. The fund owned 35,654 shares of the company’s stock after buying an additional 4,787 shares during the period. Royce & Associates LP’s holdings in Molina Healthcare were worth $10,377,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors also recently modified their holdings of the company. State Street Corp boosted its position in shares of Molina Healthcare by 0.5% during the 3rd quarter. State Street Corp now owns 2,614,311 shares of the company’s stock valued at $900,787,000 after acquiring an additional 13,001 shares in the last quarter. Charles Schwab Investment Management Inc. lifted its stake in Molina Healthcare by 2.6% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 400,080 shares of the company’s stock worth $116,443,000 after purchasing an additional 10,002 shares during the period. Los Angeles Capital Management LLC boosted its holdings in Molina Healthcare by 166.1% during the fourth quarter. Los Angeles Capital Management LLC now owns 196,513 shares of the company’s stock valued at $57,195,000 after purchasing an additional 122,674 shares in the last quarter. Swiss National Bank grew its stake in shares of Molina Healthcare by 0.3% in the 3rd quarter. Swiss National Bank now owns 173,900 shares of the company’s stock valued at $59,919,000 after purchasing an additional 500 shares during the period. Finally, Sumitomo Mitsui Trust Group Inc. raised its holdings in shares of Molina Healthcare by 2.2% in the 4th quarter. Sumitomo Mitsui Trust Group Inc. now owns 149,573 shares of the company’s stock worth $43,533,000 after buying an additional 3,238 shares in the last quarter. Institutional investors and hedge funds own 98.50% of the company’s stock.

Insider Transactions at Molina Healthcare

In other Molina Healthcare news, Director Steven J. Orlando sold 1,000 shares of the firm’s stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $301.33, for a total value of $301,330.00. Following the transaction, the director now directly owns 17,375 shares of the company’s stock, valued at approximately $5,235,608.75. This trade represents a 5.44 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.10% of the stock is owned by corporate insiders.

Molina Healthcare Stock Up 2.8 %

NYSE MOH opened at $316.70 on Tuesday. The stock has a market capitalization of $17.58 billion, a P/E ratio of 15.50, a price-to-earnings-growth ratio of 1.06 and a beta of 0.56. Molina Healthcare, Inc. has a 52 week low of $262.32 and a 52 week high of $423.92. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.62 and a current ratio of 1.62. The stock has a fifty day moving average of $298.06 and a 200-day moving average of $310.37.

Molina Healthcare (NYSE:MOH) last announced its quarterly earnings data on Wednesday, February 5th. The company reported $5.05 EPS for the quarter, missing analysts’ consensus estimates of $5.74 by ($0.69). Molina Healthcare had a return on equity of 28.13% and a net margin of 2.90%. On average, equities research analysts forecast that Molina Healthcare, Inc. will post 24.4 EPS for the current year.

Analyst Upgrades and Downgrades

Several analysts recently commented on the company. Stephens reaffirmed an “equal weight” rating and issued a $345.00 price target on shares of Molina Healthcare in a research note on Thursday, February 6th. Truist Financial lowered their target price on shares of Molina Healthcare from $370.00 to $340.00 and set a “buy” rating on the stock in a report on Wednesday, February 19th. Barclays cut their price target on shares of Molina Healthcare from $372.00 to $339.00 and set an “equal weight” rating for the company in a report on Friday, February 7th. JPMorgan Chase & Co. reaffirmed a “neutral” rating and set a $350.00 price objective (down previously from $378.00) on shares of Molina Healthcare in a report on Tuesday, December 17th. Finally, UBS Group cut their target price on shares of Molina Healthcare from $374.00 to $325.00 and set a “neutral” rating for the company in a research note on Friday, February 7th. One analyst has rated the stock with a sell rating, seven have given a hold rating, six have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $355.69.

Molina Healthcare Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.